We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

137 hedge funds and large institutions have $832M invested in Epizyme, Inc in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 41 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,192% more call options, than puts

Call options by funds: $22.3M | Put options by funds: $1.73M

24% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 41

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

0% more funds holding

Funds holding: 137 → 137 (0)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

20% less capital invested

Capital invested by funds: $1.04B → $832M (-$212M)

Holders
137
Holders Change
–
Holders Change %
0%
% of All Funds
2.41%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
18
Increased
51
Reduced
41
Closed
15
Calls
$22.3M
Puts
$1.73M
Net Calls
+$20.6M
Net Calls Change
-$6.19M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$14M
2
BlackRock
BlackRock
New York
+$4.98M
3
Millennium Management
Millennium Management
New York
+$4.41M
4
Two Sigma Investments
Two Sigma Investments
New York
+$3.69M
5
GIM
Granahan Investment Management
Massachusetts
+$3.39M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$27.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$7.57M
3
RG
Redmile Group
California
-$6.48M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$6.23M
5
BCM
Burrage Capital Management
Massachusetts
-$3.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$5.15M +$4.41M +426,331 +258%
BCM
27
Burrage Capital Management
Massachusetts
$4.92M -$3.79M -365,912 -39%
N
28
Nuveen
North Carolina
$3.17M -$21.7K -2,096 -0.6%
Two Sigma Investments
29
Two Sigma Investments
New York
$3.11M +$3.69M +356,702 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.01M -$57.3K -5,535 -2%
Citigroup
31
Citigroup
New York
$2.98M +$3.02M +291,514 +581%
Deutsche Bank
32
Deutsche Bank
Germany
$2.73M +$156K +15,072 +5%
Voloridge Investment Management
33
Voloridge Investment Management
Florida
$2.67M +$1.27M +122,270 +66%
FCMI
34
Foresite Capital Management I
California
$2.56M – – –
HWAM
35
Hennion & Walsh Asset Management
New Jersey
$2.49M +$2.95M +285,562 New
Rafferty Asset Management
36
Rafferty Asset Management
New York
$2.38M +$2.42M +233,874 +601%
RPAM
37
Rhenman & Partners Asset Management
Sweden
$2.31M – – –
JP Morgan Chase
38
JP Morgan Chase
New York
$2.12M -$246K -23,775 -9%
Marshall Wace
39
Marshall Wace
United Kingdom
$1.81M +$2.15M +207,760 New
Macquarie Group
40
Macquarie Group
Australia
$1.79M -$10.9K -1,049 -0.5%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$1.58M – – –
Barclays
42
Barclays
United Kingdom
$1.57M +$456K +44,042 +32%
Swiss National Bank
43
Swiss National Bank
Switzerland
$1.42M +$21.7K +2,100 +1%
Russell Investments Group
44
Russell Investments Group
United Kingdom
$1.34M +$822K +79,419 +106%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$1.32M -$14.2K -1,375 -0.9%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$1.17M -$5.07K -490 -0.4%
CS
47
Candriam SCA
Luxembourg
$1.1M – – –
WJWM
48
Williams Jones Wealth Management
New York
$1.1M -$155K -15,021 -11%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$1.04M -$70.4K -6,800 -5%
CS
50
Credit Suisse
Switzerland
$1.04M -$838K -80,947 -40%
1
2
3 4 5

EPZM Hedge Fund Activity: Q1 2021 in Review

137 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q1 2021, worth a combined $832M — down 20% from $1.04B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new EPZM positions and 15 closed out — a net gain of 3 holders — while 51 added to existing stakes and 41 trimmed.

The largest buyer was State Street, adding an estimated $14M. The largest seller was Victory Capital Management, cutting an estimated $27.5M.

  • 137 institutional investors held Epizyme, Inc (EPZM) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $832M of Epizyme, Inc stock for Q1 2021, down 20% quarter-over-quarter.
  • 18 funds opened new Epizyme, Inc positions in Q1 2021 and 15 closed out, a net change of +3 holders.
  • The largest Epizyme, Inc buyer in Q1 2021 was State Street, an estimated $14M added.
  • The largest Epizyme, Inc seller in Q1 2021 was Victory Capital Management, an estimated $27.5M sold.

Based on aggregated 13F filings for Q1 2021.